Local supply of a medicine used to prevent malaria across Africa received a boost recently, as the World Health Organization (WHO) issued a quality certification to the first African manufacturer of a key antimalarial drug used to prevent infection in pregnant women and children. Called pre- qualification, this certification will enable Kenyan manufacturer Universal Corporation Ltd (UCL) to support regional efforts to combat malaria through local production of high-quality sulfadoxine-pyrimethamine (SP).
- Read more about First African medicine to prevent malaria approved by WHO
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/first-african-medicine-to-prevent-malaria-approved-by-who
No comments:
Post a Comment